Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05895500 · ClinicalTrials.gov registry record
Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia
A clinical trial of Dry Eye and Asthenopia, sponsored by Nvision Laser Eye Centers.
- Completed
- Registry status
- 103
- Enrollment target
- 1
- Study location
NCT05895500 is a study of Dry Eye and Asthenopia that has completed, run by Nvision Laser Eye Centers. The registered enrollment target is 103 participants, above the 93-participant average among 41 other Dry Eye trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05895500, a study of Dry Eye and Asthenopia, has completed, sponsored by Nvision Laser Eye Centers.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
Safety and Efficacy of Medications for Migraine in Patients with Dry Eye Disease or Asthenopia
Conditions Studied
Interventions
- DRUG Injection for SC administration (120mg/syringe)
- DRUG Tablet (50mg/tablet), oral
Study Locations (1)
California
- NVision-EWEI-Torrance - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2023-05-10 |
| Est. Completion | 2023-11-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05895500
The ClinicalTrials.gov registry entry for NCT05895500 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 93-participant average among 41 other Dry Eye trials with a reported enrollment target (11% higher). The listed sponsor is Nvision Laser Eye Centers, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Dry Eye appearing as the primary indexed condition, and to 2 interventions - of which Injection for SC administration (120mg/syringe) is the first listed.
NCT05895500 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05895500 about?
NCT05895500 is a clinical study titled "Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia". Safety and Efficacy of Medications for Migraine in Patients with Dry Eye Disease or Asthenopia
What is the current status of trial NCT05895500?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2023-05-10. Estimated completion is 2023-11-09.
What conditions does trial NCT05895500 study?
This clinical trial studies the following conditions: Dry Eye, Asthenopia.
What interventions are being tested in trial NCT05895500?
The interventions under investigation include: Injection for SC administration (120mg/syringe) (DRUG), Tablet (50mg/tablet), oral (DRUG).
Who is sponsoring clinical trial NCT05895500?
This trial is sponsored by Nvision Laser Eye Centers, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05895500 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Kera Sol Tears on Signs and Symptoms of Surgical Temporary Ocular Discomfort Syndrome (STODS) in Subjects Following LASIK
RECRUITING · Phase 4
-
The THINK Study Incidence of Neurotrophic Keratopathy)
RECRUITING · NA
-
Low Level Light Therapy & Skin Pigmentation
RECRUITING · NA
-
Quality of Life in Presbyopic Patients Who Are Treated With Qlosi
RECRUITING · Phase 4
-
A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
RECRUITING · Phase 2
-
Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.